Insider Trading Alert - MPWR, NUVA, CERN, WFC And FLR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Nov. 8, 2013, 143 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $296.78 to $400,200,000.00.

Highlighted Stocks Traded by Insiders:

Monolithic Power Systems (MPWR) - FREE Research Report

Chang Kuo Wei Herbert who is Director at Monolithic Power Systems sold 4,000 shares at $32.00 on Nov. 8, 2013. Following this transaction, the Director owned 41,762 shares meaning that the stake was reduced by 8.74% with the 4,000 share transaction.

Xiao Deming who is Pres. of MPS Asia Operations at Monolithic Power Systems sold 3,558 shares at $31.36 on Nov. 8, 2013. Following this transaction, the Pres. of MPS Asia Operations owned 73,131 shares meaning that the stake was reduced by 4.64% with the 3,558 share transaction.

Hsing Michael who is Ceo at Monolithic Power Systems sold 8,167 shares at $31.29 on Nov. 8, 2013. Following this transaction, the Ceo owned 328,436 shares meaning that the stake was reduced by 2.43% with the 8,167 share transaction.

The shares most recently traded at $31.49, up $0.20, or 0.63% since the insider transaction. Historical insider transactions for Monolithic Power Systems go as follows:

  • 4-Week # shares sold: 245,013
  • 12-Week # shares sold: 285,013
  • 24-Week # shares sold: 424,673

The average volume for Monolithic Power Systems has been 352,400 shares per day over the past 30 days. Monolithic Power Systems has a market cap of $1.2 billion and is part of the technology sector and electronics industry. Shares are up 40.08% year to date as of the close of trading on Friday.

Monolithic Power Systems, Inc., a fabless semiconductor company, designs, develops, and markets analog and mixed-signal semiconductors for the communications, computing, consumer, and industrial markets. The company has a P/E ratio of 78.0. Currently there are 6 analysts that rate Monolithic Power Systems a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MPWR - FREE

TheStreet Quant Ratings rates Monolithic Power Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Monolithic Power Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

NuVasive (NUVA) - FREE Research Report

Lukianov Alexis V who is Chairman & CEO at NuVasive sold 5,000 shares at $31.45 on Nov. 8, 2013. Following this transaction, the Chairman & CEO owned 72,827 shares meaning that the stake was reduced by 6.42% with the 5,000 share transaction.

The shares most recently traded at $31.89, up $0.44, or 1.39% since the insider transaction. Historical insider transactions for NuVasive go as follows:

  • 4-Week # shares sold: 43,388
  • 12-Week # shares sold: 68,535
  • 24-Week # shares sold: 77,233

The average volume for NuVasive has been 403,400 shares per day over the past 30 days. NuVasive has a market cap of $1.4 billion and is part of the health care sector and health services industry. Shares are up 102.13% year to date as of the close of trading on Friday.

NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedurally integrated solutions for the spine. The company's products focus on applications for spine fusion surgery. Currently there are 8 analysts that rate NuVasive a buy, no analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NUVA - FREE

TheStreet Quant Ratings rates NuVasive as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full NuVasive Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Cerner Corporation (CERN) - FREE Research Report

Patterson Neal L who is Chairman and CEO at Cerner Corporation sold 4,000 shares at $55.67 on Nov. 8, 2013. Following this transaction, the Chairman and CEO owned 317,000 shares meaning that the stake was reduced by 1.25% with the 4,000 share transaction.

The shares most recently traded at $56.72, up $1.05, or 1.85% since the insider transaction. Historical insider transactions for Cerner Corporation go as follows:

  • 24-Week # shares sold: 2,870

The average volume for Cerner Corporation has been 1.5 million shares per day over the past 30 days. Cerner Corporation has a market cap of $19.3 billion and is part of the technology sector and computer software & services industry. Shares are up 44.7% year to date as of the close of trading on Friday.

Cerner Corporation designs, develops, markets, installs, hosts, and supports healthcare information technology, healthcare devices, hardware, and content solutions for healthcare organizations and consumers worldwide. The company has a P/E ratio of 43.8. Currently there are 9 analysts that rate Cerner Corporation a buy, 1 analyst rates it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CERN - FREE

TheStreet Quant Ratings rates Cerner Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Cerner Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Wells Fargo (WFC) - FREE Research Report

Dean Lloyd H who is Director at Wells Fargo sold 6,702 shares at $42.52 on Nov. 8, 2013. Following this transaction, the Director owned 27,670 shares meaning that the stake was reduced by 19.5% with the 6,702 share transaction.

The shares most recently traded at $42.67, up $0.15, or 0.35% since the insider transaction. Historical insider transactions for Wells Fargo go as follows:

  • 12-Week # shares sold: 9,307
  • 24-Week # shares sold: 164,100

The average volume for Wells Fargo has been 17.2 million shares per day over the past 30 days. Wells Fargo has a market cap of $219.7 billion and is part of the financial sector and banking industry. Shares are up 22.03% year to date as of the close of trading on Friday.

Wells Fargo & Company provides retail, commercial, and corporate banking services. The stock currently has a dividend yield of 2.88%. The company has a P/E ratio of 11.0. Currently there are 10 analysts that rate Wells Fargo a buy, 1 analyst rates it a sell, and 13 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WFC - FREE

TheStreet Quant Ratings rates Wells Fargo as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, expanding profit margins and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Wells Fargo Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Fluor Corporation (FLR) - FREE Research Report

Porter Biggs C who is Senior V.P. and CFO at Fluor Corporation sold 13,078 shares at $76.83 on Nov. 8, 2013. Following this transaction, the Senior V.P. and CFO owned 62,857 shares meaning that the stake was reduced by 17.22% with the 13,078 share transaction.

The shares most recently traded at $77.41, up $0.58, or 0.75% since the insider transaction. Historical insider transactions for Fluor Corporation go as follows:

  • 4-Week # shares sold: 18,660
  • 12-Week # shares sold: 18,660
  • 24-Week # shares sold: 18,660

The average volume for Fluor Corporation has been 1.4 million shares per day over the past 30 days. Shares are up 28.82% year to date as of the close of trading on Friday.

Fluor Corporation, through its subsidiaries, provides engineering, procurement, construction, maintenance, and project management services worldwide. The company operates in five segments: Oil & Gas, Industrial & Infrastructure, Government, Global Services, and Power. The stock currently has a dividend yield of 0.85%. The company has a P/E ratio of 24.9. Currently there are 14 analysts that rate Fluor Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FLR - FREE

TheStreet Quant Ratings rates Fluor Corporation as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Fluor Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing